PRESERFLO™ Microshunt: 1-Year Results of a 25-Gauge vs. 27-Gauge Needle Tract
<b>Background:</b> The purpose of this study was to evaluate the effectiveness and safety of the PreserFlo™ microshunt (PMS) using a 25-Gauge vs. 27-Gauge needle tract. <b>Methods</b>: This is a prospective postoperative examination of 60 glaucoma eyes that received a PMS. Th...
Main Authors: | Stefan Steiner, Hemma Resch, Barbara Kiss, Clemens Vass |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/7/1979 |
Similar Items
-
PreserFlo MicroShunt® exposure: a case series
by: Roxane Bunod, et al.
Published: (2021-07-01) -
PreserFlo Microshunt for the management of intraocular pressure elevation in iridocorneal endothelial syndrome
by: Sunil Ruparelia, et al.
Published: (2023-12-01) -
Tube obstruction caused by intraocular lens capture following PreserFlo MicroShunt implantation
by: Kentaro Iwasaki, et al.
Published: (2024-03-01) -
Case report: Surgical management of vitreous obstruction following PreserFlo ® MicroShunt implantation
by: Giovanni Tondini, et al.
Published: (2023-12-01) -
A New and Easier Approach to Preserflo MicroShunt Implantation
by: Fea AM, et al.
Published: (2022-04-01)